PFCSIG CEM FEM STEM 5DG13X90MM
Report
- Report Number
- 1818910-2016-31106
- Event Type
- Injury
- Date Received
- November 8, 2016
- Date of Event
- September 19, 2016
- Report Date
- November 2, 2016
- Manufacturer
- DEPUY-RAYNHAM 1219655
- Product Code
- NJL
- PMA / PMN Number
- P830055
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI, US
- Reporter Occupation
- PHYSICIAN
Narratives
IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. (B)(4). (THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.
EXAMINATION OF THE SUBMITTED DEVICE CONFIRMED FRACTURE DUE TO LOW-STRESS, HIGH-CYCLE FATIGUE. THERE WAS NO EVIDENCE OF INCLUSIONS OR OTHER MATERIAL DEFECTS THAT COULD HAVE CONTRIBUTED TO CRACK INITIATION OR PROPAGATION. REVIEW OF THE DEVICE HISTORY RECORDS DID NOT REVEAL ANY MANUFACTURING DEVIATIONS OR ANOMALIES. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. NO EVIDENCE WAS FOUND INDICATING PRODUCT ERROR WAS A CONTRIBUTING FACTOR TO THE REPORTED EVENT AND THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.
PATIENT WAS REVISED TO ADDRESS PAIN, OSTEOLYSIS AND A BROKEN ADAPTOR BOLT AND LOOSE FEMORAL COMPONENT. LOOSENING OCCURRED AT THE BONE/CEMENT IMPLANT INTERFACE. CEMENT MANUFACTURED BY A COMPETITOR. UPDATE 11/2/2016: EXAMINATION OF THE SUBMITTED DEVICES FOUND THE STEM BOLT AND STEM FRACTURED. THE STEM HAS NOW BEEN ADDED AND REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 738114 | PFCSIG CEM FEM STEM 5DG13X90MM | KNEE OTHER IMPLANT | NJL | DEPUY-RAYNHAM 1219655 | 316349R |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Required Intervention |